Riskpilot← Back to searchSign inGet full accessLARVIK FYSIOTERAPI AS
ASActiveOrg 929228103Kongegata 16, 3256 LarvikPhysiotherapy activities · NACE 8695Est. 19811 employees
Revenue 2025
NOK 1,3M
+1% vs 2024
EBITDA margin
13.3%
+1262% vs 2024
Equity ratio
91.6%
Financial strength
Net profit 2025
NOK 164K
+2450% vs 2024
| Revenue | NOK 1,3M | +1% |
| EBITDA | NOK 176K | +1262% |
| Net profit | NOK 164K | +2450% |
| Total assets | NOK 322K | +92% |
| Equity | NOK 295K | +125% |
| Employees | 1 | — |
Legal name
LARVIK FYSIOTERAPI AS
Org number
929228103
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
1. januar 1981
Share capital
NOK 120 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Address
Kongegata 16, 3256 Larvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 596 | 586 | 617 | 612 | 614 | 720 | 727 | 721 | 731 | 788 | 795 | 932 | 942 | 989 | 989 | 1 188 | 1 314 | 1 326 |
| Staff expenses | −44 | −44 | −44 | −44 | −47 | −194 | −196 | −200 | −201 | −210 | −205 | −209 | −198 | −186 | −211 | −219 | −227 | −187 |
| EBITDA | 74 | 75 | 76 | 59 | 46 | 10 | 79 | 41 | 10 | 28 | −7 | 16 | −65 | 48 | 17 | −41 | 13 | 176 |
| Depreciation & amort. | −26 | −21 | −26 | −37 | −47 | −46 | −46 | −41 | −46 | −20 | −12 | −12 | −10 | −10 | −7 | −7 | −7 | −4 |
| EBIT | 48 | 54 | 51 | 22 | −1 | −36 | 34 | −0 | −36 | 9 | −19 | 4 | −75 | 39 | 11 | −47 | 6 | 172 |
| Net financials | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0 | 0 | −0 | −0 | −1 |
| Profit before tax | 46 | 54 | 51 | 22 | −1 | −36 | 34 | −0 | −36 | 9 | −19 | 4 | −75 | 38 | 11 | −47 | 6 | 171 |
| Tax | 13 | 15 | 14 | 6 | −0 | −0 | 6 | 1 | 0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | 8 |
| Net profit | 33 | 39 | 37 | 16 | −1 | −36 | 28 | −1 | −36 | 9 | −19 | 4 | −75 | 38 | 11 | −47 | 6 | 164 |
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 165 | 207 | 250 | 248 | 274 | 238 | 267 | 263 | 213 | 236 | 215 | 232 | 175 | 201 | 206 | 218 | 167 | 322 |
| Equity | 147 | 186 | 223 | 238 | 237 | 202 | 229 | 228 | 193 | 202 | 183 | 198 | 123 | 161 | 172 | 125 | 131 | 295 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 18 | 22 | 27 | 10 | 36 | 36 | 38 | 34 | 20 | 34 | 32 | 34 | 53 | 40 | 34 | 93 | 36 | 27 |
| Total debt | 18 | 22 | 27 | 10 | 36 | 36 | 38 | 34 | 20 | 34 | 32 | 34 | 53 | 40 | 34 | 93 | 36 | 27 |
EBITDA margin
13.3%
This company
15.8%
Market median
-16% vs market
20082025
Equity ratio
91.6%
This company
38.2%
Market median
+140% vs market
20082025
Return on equity
55.5%
This company
18.4%
Market median
+202% vs market
20082025
Net profit margin
12.3%
This company
8.1%
Market median
+52% vs market
20082025
Asset turnover
4.12×
This company
1.12×
Market median
+268% vs market
20082025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20082025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OF Chief Executive Officer | Chief Executive Officer | 1995 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2001 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LARVIK FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olav Frode Aure | Chief Executive Officer | 0 companies |
| Arnfinn Tveisme | Board of Directors | 0 companies |
| Hilde Eskedal | Board of Directors | 0 companies |
| Bernt Waale | Chairman | 0 companies |
| Fanny Christin Windingstad Stavelin | Board of Directors | 0 companies |
| Trygve Brynjar Fagerås | Board of Directors | 0 companies |